7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Uremia D014511 33 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Middleton K et al. Microfluidic co-culture platform for investigating osteocyte-osteoclast signalling during fluid shear stress mechanostimulation. 2017 J Biomech pmid:28552413
Jung YJ et al. Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. 2017 Mol Oral Microbiol pmid:27484636
Lu LY et al. Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. 2017 J. Orthop. Res. pmid:28248001
Kuroyanagi G et al. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. 2017 Prostaglandins Other Lipid Mediat. pmid:28163121
Liu XY et al. Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway. 2017 Int. Immunopharmacol. pmid:28092862
Choi EM et al. Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. 2017 Environ. Toxicol. pmid:28836330
Chen X et al. Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation. 2017 Environ. Toxicol. Pharmacol. pmid:28738286
Ozaki Y et al. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. 2017 PLoS ONE pmid:28937990
Tschiderer L et al. Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. 2017 PLoS ONE pmid:28837646
Åšliwicka E et al. Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. 2017 PLoS ONE pmid:28732027
Bergdolt S et al. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. 2017 PLoS ONE pmid:28614388
Spirlandeli AL et al. Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. 2017 Clinics (Sao Paulo) pmid:28492723
Liu J et al. MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. 2017 PLoS ONE pmid:28319142
Songia P et al. Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. 2017 Oxid Med Cell Longev pmid:28261377
Jia J et al. Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. 2017 Mol Med Rep pmid:28260003
Shetelig C et al. Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. 2017 PLoS ONE pmid:28253327
Irtyuga O et al. NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. 2017 Biomed Res Int pmid:28246602
Hanmoto T et al. Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. 2017 Biomed. Res. pmid:28239034
Fioramonti M et al. Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. 2017 Oncotarget pmid:28223547
Xiong L et al. Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. 2017 J. Cell Biol. pmid:28193701
Fortner RT et al. Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. 2017 BMC Med pmid:28173834
Chung ST et al. Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. 2017 Mol. Cancer pmid:28143606
Yin LL et al. Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. 2017 Eur Rev Med Pharmacol Sci pmid:28121359
Bondar C et al. Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. 2017 Int J Mol Sci pmid:28098793
Shu R et al. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. 2017 PLoS ONE pmid:28081119
Ji J et al. Pathway of 3-MCPD-induced apoptosis in human embryonic kidney cells. 2017 J Toxicol Sci pmid:28070108
Sponder M et al. Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. 2017 BMC Cardiovasc Disord pmid:28056805
Hygum K et al. MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. 2017 Eur. J. Endocrinol. pmid:28049653
Dawson S and Lawrie A From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. 2017 Pharmacol. Ther. pmid:27373854
Yu M et al. Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. 2016 Apr-Jun J Cancer Res Ther pmid:27461682
Gautam J et al. An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. 2016 J. Pharm. Pharmacol. pmid:27265669
Owen S et al. Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. 2016 Int. J. Oncol. pmid:26781475
Maser RE et al. Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. 2016 J. Diabetes Complicat. pmid:26775555
Gottesman GS et al. Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. 2016 Am. J. Med. Genet. A pmid:26762549
Totoson P et al. Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation. 2016 PLoS ONE pmid:26761790
Kuroda Y et al. Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. 2016 PLoS ONE pmid:26751951
Bougioukli S et al. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. 2016 Bone pmid:26723577
Wang HL et al. Protein biomarkers and microbial profiles in peri-implantitis. 2016 Clin Oral Implants Res pmid:26424287
Iezaki T et al. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption. 2016 J. Bone Miner. Res. pmid:26391411
Meijome TE et al. C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis. 2016 J. Cell. Biochem. pmid:26375403
Liu FQ et al. Effects of Salt Loading on Plasma Osteoprotegerin Levels and Protective Role of Potassium Supplement in Normotensive Subjects. 2016 Circ. J. pmid:27867157
Kim CS et al. Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. 2016 PLoS ONE pmid:27855207
Li XJ et al. Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. 2016 Int. J. Mol. Med. pmid:27840967
Zhou J and Zhao Y Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population. 2016 Med. Sci. Monit. pmid:27828936
Ostrowska Z et al. TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. 2016 Endokrynol Pol pmid:27828689
Ye C et al. [Effect of MT01/PEN complexes on the expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in human osteoblast-like cell line MG63]. 2016 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:27266195
Bernardi S et al. Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. 2016 Biomed Res Int pmid:27200369
Wei CC et al. Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis. 2016 Mediators Inflamm. pmid:27199510
Usategui-Martín R et al. VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone. 2016 Genet Test Mol Biomarkers pmid:27172236
Li B et al. Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity. 2016 Int J Mol Sci pmid:27110777

Table of Content